News & Press Releases

Development and commercialisation of new curative anti-malarial treatments.

March 2011

Arenco & Brussels University (VUB) successfully complete the development program : "Development of an innovative pediatric ACT" supported by the local government ( IWT )

September 2010

Arenco’s CEO contributes t the WHO’s ‘Global Plan for Artemisinin Resistance Containment (GPARC). See the final report ( here )

July 2010

Arenco becomes a member of Flanders-Bio:

November 2009

Arenco’s CEO is invited to attend the "Fourth MIM Pan-African Malaria Conference" in Nairobi, courtesy of EU DG Research & Innovation.

© 2011-2014 Arenco Pharmaceutica NV